Nampt: linking NAD biology, metabolism and cancer
- 30 April 2009
- journal article
- review article
- Published by Elsevier BV in Trends in Endocrinology & Metabolism
- Vol. 20 (3), 130-138
- https://doi.org/10.1016/j.tem.2008.10.004
Abstract
No abstract availableKeywords
Funding Information
- Juvenile Diabetes Research Foundation International
- American Diabetes Association
- Longer Life Foundation
- National Institute on Aging (AG024150)
- EMD Serono
- Deutsche Forschungsgemeinschaft (KFO 152)
- Novo Nordisk
- Ellison Medical Foundation
- Ipsen
This publication has 93 references indexed in Scilit:
- Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling MechanismOnline Journal of Public Health Informatics, 2008
- Insulin sensitivity: modulation by nutrients and inflammationJCI Insight, 2008
- Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NADPLOS ONE, 2008
- Glucose Restriction Inhibits Skeletal Myoblast Differentiation by Activating SIRT1 through AMPK-Mediated Regulation of NamptDevelopmental Cell, 2008
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Age‐associated loss of Sirt1‐mediated enhancement of glucose‐stimulated insulin secretion in beta cell‐specific Sirt1‐overexpressing (BESTO) miceAging Cell, 2007
- Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic EnzymeCell Metabolism, 2007
- Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell SurvivalCell, 2007
- Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary AtherosclerosisCirculation, 2007
- Nampt/PBEF/Visfatin: A regulator of mammalian health and longevity?Experimental Gerontology, 2006